IRIS
LIAKOULI, Vasiliki
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.337
AS - Asia 2.619
EU - Europa 2.505
SA - Sud America 274
AF - Africa 42
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 7
Totale 9.795
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.280
SG - Singapore 1.210
IE - Irlanda 692
CN - Cina 619
SE - Svezia 360
TR - Turchia 321
IT - Italia 293
HK - Hong Kong 271
DE - Germania 261
BR - Brasile 246
RU - Federazione Russa 246
UA - Ucraina 195
GB - Regno Unito 174
FI - Finlandia 86
FR - Francia 81
VN - Vietnam 75
CA - Canada 38
IN - India 38
BE - Belgio 35
NL - Olanda 21
ZA - Sudafrica 21
JP - Giappone 17
PL - Polonia 16
BD - Bangladesh 13
MX - Messico 13
ID - Indonesia 11
ES - Italia 10
CZ - Repubblica Ceca 8
AR - Argentina 7
AU - Australia 6
EC - Ecuador 6
EU - Europa 6
IQ - Iraq 5
LT - Lituania 5
MA - Marocco 5
NZ - Nuova Zelanda 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
VE - Venezuela 5
CO - Colombia 4
JO - Giordania 4
LB - Libano 4
DZ - Algeria 3
EG - Egitto 3
IR - Iran 3
JM - Giamaica 3
PT - Portogallo 3
TN - Tunisia 3
AL - Albania 2
AT - Austria 2
BO - Bolivia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
DK - Danimarca 2
GR - Grecia 2
IL - Israele 2
KE - Kenya 2
LU - Lussemburgo 2
MY - Malesia 2
PK - Pakistan 2
PY - Paraguay 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
MD - Moldavia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
SN - Senegal 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 9.795
Salva come PNG Salva come JPEG
Città #
Jacksonville 775
Chandler 723
Dublin 692
Singapore 641
Dallas 290
Hong Kong 270
Santa Clara 235
Boardman 230
Izmir 201
Ashburn 199
Ann Arbor 135
New York 131
Nanjing 121
Beijing 107
Lawrence 101
Princeton 101
Wilmington 100
San Mateo 93
L'aquila 72
The Dalles 62
Moscow 61
Woodbridge 51
Dearborn 49
Los Angeles 48
Milan 46
Nanchang 43
Brussels 35
Munich 33
Shenyang 30
Seattle 28
Mountain View 27
Hefei 26
Verona 26
Kunming 25
São Paulo 25
Helsinki 24
Jiaxing 23
Hebei 22
Dong Ket 20
Ho Chi Minh City 20
Shanghai 20
Changsha 18
Rome 18
Tokyo 17
Des Moines 16
Columbus 15
Frankfurt am Main 15
Johannesburg 15
Phoenix 15
Tianjin 15
L’Aquila 14
Warsaw 14
Council Bluffs 13
Jinan 13
Hanoi 12
Montreal 12
Chicago 11
Houston 11
Zhengzhou 11
London 9
Ningbo 9
Pune 9
Rio de Janeiro 9
Stockholm 9
Denver 8
Grafing 8
Guangzhou 8
Manchester 8
San Francisco 8
San Jose 8
Toronto 8
Atlanta 7
Chennai 7
Falkenstein 7
Hangzhou 7
Norwalk 7
Orem 7
Pescara 7
Philadelphia 7
Ankara 6
Bremen 6
Brno 6
Jakarta 6
Poplar 6
Salerno 6
Belo Horizonte 5
Lanzhou 5
Tashkent 5
Amman 4
Amsterdam 4
Brooklyn 4
Changchun 4
Charlotte 4
Edinburgh 4
Fremont 4
Goiânia 4
La Spezia 4
Mexico City 4
Mumbai 4
Naples 4
Totale 6.472
Salva come PNG Salva come JPEG
Nome #
Studio dell’espressione della chemochina SDF-1 e del suo recettore CXCR4 nella cute e nelle cellule endoteliali microvascolari di pazienti affetti da sclerosi sistemica (SSc). 172
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 145
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 140
Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients 139
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 136
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 133
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 132
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy. 131
The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis. 130
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 129
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 128
association of pathogenic and regulatory B-cell subsets with clinical and histological features in primary Sjogren's syndrome. 125
H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 123
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 120
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 119
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 114
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 114
Stromal Cell-derived Factor 1 in Cardiac and Autoimmune Disease 113
Cardiovascular disease in primary sjögren’s syndrome 113
Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients. 112
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 111
Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis 109
Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis 109
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 109
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. 108
Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren's syndrome minor salivary glands 107
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies a very early cardiac involvement in systemic sclerosis patients of recent onset 106
Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort 105
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 105
Association of a functional polymorphism in the matrix metalloproteinase-12 promoter region with systemic sclerosis in an Italian population. 104
Searching for a good model for systemic sclerosis: The molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis 103
Efficacy of inhibition of IL-1 in patients with rheumatoid arthritis and type 2 diabetes mellitus: two case reports and review of the literature. 102
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 102
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features. 102
SENESCENT BONE MARROW DERIVED MESENCHYMAL STEM CELLS (MSC) ARE PRONE TO RECOVER DURING SSC 101
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS. 101
Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts 101
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. 100
Linking myofibroblast generation and microvascular alteration: The role of CD248 from pathogenesis to therapeutic target (Review) 99
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis. 99
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 98
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis 97
The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis. 96
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 96
FAS -670 gene promoter polymorphism confers susceptibility to systemic sclerosis 95
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units 95
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study. 95
Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study 94
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 94
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 93
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 92
Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine. 92
Interstitial lung disease in systemic sclerosis: current and future treatment. 92
Decreased Expression of Angiopoetin 1 on Perivascular Mesenchymal Stem Cells from Ssc Patients Induces an Anti Angiogenetic Effect, when Co-cultured with Endothelial Cells 91
Variations of neuronal nitric oxide synthase in systemic sclerosis skin 90
SDF-1/CXCR4 system in microvascular endothelial cells and skin from patients affected by systemic sclerosi 90
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 90
Myofibroblast Cells Expression of CD248 May Contribute to Exacerbate Microvascular Damage during Systemic Sclerosis 90
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 89
Scleroderma fibroblasts suppress angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment epithelium-derived factor 89
Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis 88
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study. 88
CARDIAC MAGNETIC RESONANCE IMAGING WITH PHARMACOLOGICAL STRESS PERFUSION IN ASYMPTOMATIC PATIENTS WITH SYSTEMIC SCLEROSIS 88
IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study 88
Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI). 87
Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy. 87
IMPAIREMENT OF ENDOTHELIAL DIFFERENTIATION FROM MESENCHYMAL STEM CELLS (MSC) IN SYSTEMIC SCLEROSIS (SSC): A NEW TOOL IN PATHOGENETIC MECHANISM 86
Surface expression of fractalkine receptor (CX3CR1) on CD4+/CD28-. T cells in RA patients and correlation with atherosclerotic damage 86
Cellular players in angiogenesis during the course of systemic sclerosis. 85
FRI0414 Evaluation of a novel multi-analyte assay for the detection of autoantibodies in the diagnosis of systemic sclerosis 85
Methotrexate: an old new drug in autoimmune disease. 84
Virtual skin biopsy by optical coherence tomography: the first quantitative imaging biomarker for scleroderma. 84
SDF-1 expression in the skin of SSc patients. 83
The Vessels Contribute to Fibrosis in Systemic Sclerosis 83
Tocilizumab for the treatment of adult-onset Still's disease: Results from a case series 83
Differential expression of SDF-1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis: pathogenetic implication. 81
Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation? 81
Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 80
Efficacy and safety of imatinib mesylate in systemic sclerosis. A systematic review and meta-analysis 80
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with sjogren’s syndrome 79
Senescent bone marrow mesenchymal stem cells (BM-MSCS) preserve their immune-regulatory effect on t cells during systemic sclerosis (SSC). 79
Caveolin-1 orchestrates vascular endothelial growth factor (VEGF) signaling control of angiogenesis during systemic sclerosis (SSC) 79
Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial 79
Laboratory assessment in patients with suspected rheumatic musculoskeletal diseases: challenges, pitfalls and perspectives 78
Pathogenesis of the endothelial damage and related factors. 77
Mesenchymal stem cells transplantation in Systemic Sclerosis: comment on the article by ATJ Maria et al 77
SDF-1/CXCR4 system in microvascular endothelial cells and skin from patients affected by systemic sclerosis 76
Angiogenic cytokines and growth factors in systemic sclerosis. 75
Adipose stromal vascular fraction and regenerative therapy in SSc: Response to the article by Magalon et al 75
THE OCCURRENCE OF SUBCLINICAL AND CLINICAL ATHEROSCLEROSIS IN RHEUMATOID ARTHRITIS, RESULTS FROM THE 3-YEAR, MULTICENTER, PROSPECTIVE, OBSERVATIONAL, GIRRCS STUDY 75
THE IL-33/ST2 PATHWAY IN SYSTEMIC SCLEROSIS 73
Modificazioni della nitrossido-sintasi neuronale (nNOS) nella cute dei pazienti con sclerosi sistemica (SSc). 72
THU0582 Prognostic Factors of Macrophage Activation Syndrome in Adults: Analysis of 40 Cases in 2 Tertiary Referral Centers 72
ASSOCIATION OF FAS-G670A GENE POLYMORPHISM WITH SYSTEMIC SCLEROSIS 69
Interstitial lung disease in systemic sclerosis: Pathophysiology and therapy 69
VASCULAR SMOOTH MUSCLE CELLS (SMC) PROGENITORS: NEW PLAYERS IN SYSTEMIC SCLEROSIS (SSC) DEFECTIVE VESSEL REGENERATION. 68
Endothelial Progenitor Cells (EPC) characterization in systemic sclerosis (SSc) patients 66
 Epidermal growth factor-like domain 7 (EGFL7) in skin of systemic sclerosis 66
DIFFERENTIAL EXPRESSION OF SDF-1 AND ITS RECEPTOR CXCR4 IN THE SKIN AND ENDOTHELIAL CELLS OF SYSTEMIC SCLEROSIS PATIENTS: PATHOGENETIC IMPLICATION 63
Potential of stem cells in the treatment of rheumatic disease 59
Totale 9.642
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.026
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.026
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021550 0 0 0 0 0 39 123 7 105 45 171 60
2021/2022637 42 36 162 53 13 10 9 27 44 35 47 159
2022/20232.035 153 127 32 238 160 215 4 118 882 15 63 28
2023/2024484 71 35 28 51 50 158 10 25 1 22 9 24
2024/20251.974 39 38 187 62 339 154 224 149 432 82 142 126
2025/20261.788 235 346 144 428 405 230 0 0 0 0 0 0
Totale 9.948